MetaCap

Apollomics Insider Trades

NASDAQ: APLMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.54-1.16 (-6.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $8.25M
Sales
0 · $0
Shares bought / sold
583.33K / 0
Net activity
Net buying $8.3 million

Apollomics insider activity

Over the last 12 months, Apollomics insiders reported 28 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $8.3 million and sold $0 worth of stock, for net insider buying of $8.3 million. The most recent filing shows Huang Ya-Chi (Director) reporting a transaction in 500 shares on Nov 17, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put APLM's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

APLM insider transactions

Apollomics insider transactions
DateInsiderTypeSharesValueFiling
Nov 17, 2026Huang Ya-ChiDirectorOption exercise500—Form 4
Sep 15, 2026Yen Hung HsienDirectorOption exercise500—Form 4
Sep 15, 2026TSAI HSIEN-SHUDirectorOption exercise500—Form 4
Sep 15, 2026Chen Hung-WenChief Executive OfficerOption exercise5,000—Form 4
Sep 15, 2026Chen Yi-KueiChief Operating OfficerOption exercise5,000—Form 4
Sep 15, 2026CHEN HONG-JUNGDirectorOption exercise500—Form 4
Sep 15, 2026LIN PETER KUAN-HOWChief Financial OfficerTax withholding3,416$82.05KForm 4
Sep 15, 2026LIN PETER KUAN-HOWChief Financial OfficerOption exercise10,000—Form 4
Sep 15, 2026Yen Hung HsienDirectorOption exercise500—Form 4
Sep 15, 2026Chen Yi-KueiChief Operating OfficerOption exercise5,000—Form 4
Sep 15, 2026LIN PETER KUAN-HOWChief Financial OfficerTax withholding3,416$82.05KForm 4
Sep 15, 2026LIN PETER KUAN-HOWChief Financial OfficerOption exercise10,000—Form 4
Aug 17, 2026Huang Ya-ChiDirectorOption exercise500—Form 4
Aug 14, 2026Chen Hung-WenChief Executive OfficerBuy266,667$4.00MForm 4
Aug 14, 2026Chen Hung-WenChief Executive OfficerBuy103,333$1.55MForm 4
Aug 14, 2026Chen Hung-WenChief Executive OfficerBuy166,667$2.00MForm 4
Aug 14, 2026Chen Yi-KueiChief Operating OfficerBuy20,000$300.00KForm 4
Aug 14, 2026LIN PETER KUAN-HOWChief Financial OfficerBuy26,667$400.00KForm 4
Jun 15, 2026Jan Chen-HuanDirectorOption exercise500—Form 4
Jun 15, 2026Chen Yi-KueiChief Operating OfficerOption exercise5,000—Form 4
Jun 15, 2026TSAI HSIEN-SHUDirectorOption exercise500—Form 4
Jun 15, 2026CHU YI-ANDirectorOption exercise500—Form 4
Jun 15, 2026CHEN HONG-JUNGDirectorOption exercise500—Form 4
Jun 15, 2026Chen Hung-WenChief Executive OfficerOption exercise5,000—Form 4
Jun 15, 2026LIN PETER KUAN-HOWChief Financial OfficerTax withholding3,588$49.69KForm 4
Jun 15, 2026LIN PETER KUAN-HOWChief Financial OfficerOption exercise10,000—Form 4
May 17, 2026Huang Ya-ChiDirectorOption exercise500—Form 4
Mar 31, 2026LIN PETER KUAN-HOWChief Financial OfficerTax withholding3,582$56.77KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related